ArticleMicrobial biotechnology2026
Previously Uncharacterised Aliphatic Amino Acid Positions Modulate the Apparent Catalytic Activity of the EAL Domain of ZMO_1055 and Other Cyclic Di-GMP-Specific EAL Phosphodiesterases.
Article in Microbial biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The nearly ubiquitous second messenger cyclic di-GMP signalling system decides about the bacterial lifestyle transition between sessility and motility. GGDEF diguanylate cyclase and EAL phosphodiesterase domains conventionally conduct the turnover of the signalling molecule being subject to micro- and macroevolution. While highly conserved signature amino acids involved in divalent cation binding and catalysis have readily been identified, recognition of single amino acid substitutions that modulate the catalytic activity has been rare. Associated with development towards cellulose-mediated self-flocculation in Zymomonas mobilis ZM401, the A526V substitution and substitutions with amino acids with longer aliphatic side chains gradually revert the apparent catalytic activity of the EAL domain in the PAS-GGDEF-EAL ZMO1055 phosphodiesterase as monitored by flocculation, biofilm and motility assays. Remarkably, the effect of the A526V substitution equivalent is observed among other investigated GGDEF-EAL proteins. Furthermore, substitutions of aliphatic side chain amino acids at distinct alternative positions affect ZOM1055 activity, while the M525L substitution has a context-dependent effect. Thus, single amino acid substitutions outside of signature amino acid positions can even revert the target output and thus significantly contribute to the flexibility and adaptability of the cyclic di-GMP signalling network. At a phylogenetic scale, ZMO1055 homologues seem to be a current evolutionary target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.